World Health Organization (WHO) has signalled warning to the medics around the globe to gear up efforts to stop the spread of gonorrhoea antibiotic-resistant strain. U.N. health agency urged governments and medical researchers for intensive research on antibiotic-resistant bacterial infection.
The organism develops resistance against medical drugs, and is quite capable to affect inflammation, pregnancy complications, infertility and blindness. Moreover, gonorrhoea strain can also be fatal to cause maternal death. The bacterium escaping antibiotic treatment due to mutation is responsible for its rapid spread. The condition affects all antibiotics, but gonorrhoea is faster to adapt.
Officials from WHO's department of sexually transmitted diseases raised the concern of gonorrhoea strain which is rapidly becoming resistant to every drug. According to them, gonorrhoea strain will become resistant to all the treatment options available at the moment. WHO is scheduled to make public announcement of the ‘global action plan' to fight disease in the near future.
Also referred to as ‘the clap’, gonorrhoea was earlier considered a scourge of sailors and soldiers. The bacterial infection is the second most common sexually transmitted infection after chlamydia, which accounts for 106 million sexually transmitted infections annually. Health experts believe that the inappropriate use of antibiotics, together with the gonorrhoea bacteria's astonishing ability to adapt will pose several health problems.
According to a HealthPop report, gonorrhoea strain resistant to cephalosporins was first found in Japan. After identification of its threat, Centers for Disease Control and Prevention signalled warning to the medics to lookout for the cases of cephalosporin-resistant gonorrhoea.
The resistance has been detected in well-developed nations such as Britain, Australia, France, Sweden and Norway. Health experts believe that there is a great chance of cephalosporin-resistant strains circulating undetected in the countries with less-advance health systems.
Despite the fact that Bedaquiline - a medicine used to treat Multidrug-Resistant Tuberculosis (MTR TB) - hurriedly introduced last year with the motive of making India TB-free, it continues to be in trial and is still available only in six centres in the country.read more
The massive stock-out of anti-TB drugs across the nation is now followed by a grieve shortage of multi-drug-resistant TB drugs.read more